Related Experiment Video

Updated: Mar 3, 2026

Olfactory Assays for Mouse Models of Neurodegenerative Disease
07:27

Olfactory Assays for Mouse Models of Neurodegenerative Disease

Published on: August 25, 2014

22.7K

Joy of super smeller: sebum clues for PD diagnostics

Jules Morgan

    The Lancet. Neurology
    |May 3, 2017
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    Targeting Alpha Synuclein Aggregates in Cutaneous Peripheral Nerve Fibers by Free-floating Immunofluorescence Assay
    08:33

    Targeting Alpha Synuclein Aggregates in Cutaneous Peripheral Nerve Fibers by Free-floating Immunofluorescence Assay

    Published on: June 25, 2019

    8.7K
    MALDI Imaging Mass Spectrometry of Neuropeptides in Parkinson's Disease
    16:57

    MALDI Imaging Mass Spectrometry of Neuropeptides in Parkinson's Disease

    Published on: February 14, 2012

    27.0K

    Related Experiment Videos

    Last Updated: Mar 3, 2026

    Olfactory Assays for Mouse Models of Neurodegenerative Disease
    07:27

    Olfactory Assays for Mouse Models of Neurodegenerative Disease

    Published on: August 25, 2014

    22.7K
    Targeting Alpha Synuclein Aggregates in Cutaneous Peripheral Nerve Fibers by Free-floating Immunofluorescence Assay
    08:33

    Targeting Alpha Synuclein Aggregates in Cutaneous Peripheral Nerve Fibers by Free-floating Immunofluorescence Assay

    Published on: June 25, 2019

    8.7K
    MALDI Imaging Mass Spectrometry of Neuropeptides in Parkinson's Disease
    16:57

    MALDI Imaging Mass Spectrometry of Neuropeptides in Parkinson's Disease

    Published on: February 14, 2012

    27.0K

    Related Concept Videos

    Parkinson's Disease: Overview01:15

    Parkinson's Disease: Overview

    2.2K
    Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
    2.2K
    Parkinson's Disease: Treatment01:24

    Parkinson's Disease: Treatment

    1.3K
    Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
    Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
    1.3K
    Neural Regulation01:37

    Neural Regulation

    43.8K
    Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
    43.8K

    Articles linked to this work by shared authors, journal, and citation graph.

    Prevalence of unruptured intracranial aneurysms according to comorbidities, risk factors, country, and time period: a systematic review and meta-analysis.

    The Lancet. Neurology·2026

    Safety, tolerability, and efficacy of alixorexton, a selective orexin 2 receptor agonist for narcolepsy type 1 (Vibrance-1): a randomised, double-blind, placebo-controlled, phase 2 trial.

    The Lancet. Neurology·2026

    Cholinesterase inhibitors in people with dementia with Lewy bodies and cardiac conduction abnormalities.

    The Lancet. Neurology·2026

    Advances in chronic subdural haematoma management: beyond the burr hole.

    The Lancet. Neurology·2026

    Antiseizure medication use in pregnancy and the risk of poor fetal growth in the EURAP international registry: a prospective cohort study.

    The Lancet. Neurology·2026

    Intensive blood pressure lowering after spontaneous intracerebral haemorrhage for secondary stroke prevention (RECAP-ICH): a systematic review and individual participant data meta-analysis.

    The Lancet. Neurology·2026

    VRC01 exerted differential pressure on HIV-1 Env from subtypes B and C that continued in the first weeks post-diagnosis in the AMP trials.

    The Journal of infectious diseases·2026

    Point-of-care ultrasound in general medicine: establishing a new service.

    Internal medicine journal·2026

    Iodine-Vacancy BiOI Nanosheets-Embedded on Bi2O3 Electrospun Heterojunction for Label-Free Interleukin-6 Photoelectrochemical Aptasensor with High Signal-to-Noise Ratio.

    Analytical chemistry·2026

    A Multiparametric Approach Integrating Multimodal Ultrasound and Serum TPO-Ab for Differentiating Thyroid Carcinoma in Hashimoto's Thyroiditis: A Comparative Diagnostic Study with Internal Validation.

    Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine·2026

    [10 Things Cardiologists Need to Know About Cardiac Amyloidosis].

    Praxis·2026

    Infective Endocarditis: Diagnosis, Antibiotic Therapy, and Management: A Scientific Statement From the American Heart Association.

    Circulation·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us